IT201700085412A1 - Composizione per uso nella prevenzione e nel trattamento di patologie dell'apparato cardiovascolare - Google Patents

Composizione per uso nella prevenzione e nel trattamento di patologie dell'apparato cardiovascolare

Info

Publication number
IT201700085412A1
IT201700085412A1 IT102017000085412A IT201700085412A IT201700085412A1 IT 201700085412 A1 IT201700085412 A1 IT 201700085412A1 IT 102017000085412 A IT102017000085412 A IT 102017000085412A IT 201700085412 A IT201700085412 A IT 201700085412A IT 201700085412 A1 IT201700085412 A1 IT 201700085412A1
Authority
IT
Italy
Prior art keywords
prevention
treatment
composition
cardiovascular diseases
cardiovascular
Prior art date
Application number
IT102017000085412A
Other languages
English (en)
Italian (it)
Inventor
Andrea Lacorte
Germano Tarantino
Elisa Brilli
Original Assignee
Pharmanutra S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmanutra S P A filed Critical Pharmanutra S P A
Priority to IT102017000085412A priority Critical patent/IT201700085412A1/it
Priority to CA3070659A priority patent/CA3070659A1/en
Priority to JOP/2020/0012A priority patent/JOP20200012A1/ar
Priority to EA202090069A priority patent/EA202090069A1/ru
Priority to CN201880045110.6A priority patent/CN111031813A/zh
Priority to KR1020207001554A priority patent/KR20200032691A/ko
Priority to US16/631,426 priority patent/US20200206157A1/en
Priority to IL272138A priority patent/IL272138B2/en
Priority to MX2020000806A priority patent/MX2020000806A/es
Priority to PE2020000102A priority patent/PE20200794A1/es
Priority to MA049794A priority patent/MA49794A/fr
Priority to EP18762623.9A priority patent/EP3657963A1/en
Priority to BR112020000902-4A priority patent/BR112020000902B1/pt
Priority to JP2020502672A priority patent/JP2020528888A/ja
Priority to PCT/IB2018/055586 priority patent/WO2019021232A1/en
Publication of IT201700085412A1 publication Critical patent/IT201700085412A1/it
Priority to CONC2020/0000526A priority patent/CO2020000526A2/es
Priority to PH12020550031A priority patent/PH12020550031A1/en
Priority to CL2020000170A priority patent/CL2020000170A1/es
Priority to ZA2020/00461A priority patent/ZA202000461B/en
Priority to JP2023076299A priority patent/JP2023090869A/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/326—Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/15—Inorganic Compounds
    • A23V2250/156—Mineral combination
    • A23V2250/1592—Iron
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/15—Inorganic Compounds
    • A23V2250/156—Mineral combination
    • A23V2250/161—Magnesium
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/70—Vitamins
    • A23V2250/714—Vitamin K
    • A23V2250/7144—Vitamin K2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT102017000085412A 2017-07-26 2017-07-26 Composizione per uso nella prevenzione e nel trattamento di patologie dell'apparato cardiovascolare IT201700085412A1 (it)

Priority Applications (20)

Application Number Priority Date Filing Date Title
IT102017000085412A IT201700085412A1 (it) 2017-07-26 2017-07-26 Composizione per uso nella prevenzione e nel trattamento di patologie dell'apparato cardiovascolare
PE2020000102A PE20200794A1 (es) 2017-07-26 2018-07-26 Composicion para su uso en la prevencion y el tratamiento de patologias del aparato cardiovascular
MA049794A MA49794A (fr) 2017-07-26 2018-07-26 Composition utilisée dans le traitement prophylactique et thérapeutique de troubles de l'appareil cardiovasculaire
EA202090069A EA202090069A1 (ru) 2017-07-26 2018-07-26 Композиция для применения в профилактике и лечении патологий сердечно-сосудистой системы
CN201880045110.6A CN111031813A (zh) 2017-07-26 2018-07-26 用于预防和治疗心血管器官病症的组合物
KR1020207001554A KR20200032691A (ko) 2017-07-26 2018-07-26 심혈관계의 병리학적 병태를 예방 및 치료하는데 사용하기 위한 조성물
US16/631,426 US20200206157A1 (en) 2017-07-26 2018-07-26 Composition for use in the prevention and treatment of pathologies of the cardiovascular apparatus
IL272138A IL272138B2 (en) 2017-07-26 2018-07-26 The composition for use in the prevention and treatment of cardiovascular pathologies of the device
MX2020000806A MX2020000806A (es) 2017-07-26 2018-07-26 Composicion para su uso en la prevencion y el tratamiento de patologias del aparato cardiovascular.
CA3070659A CA3070659A1 (en) 2017-07-26 2018-07-26 Composition for use in the prevention and treatment of pathologies of the cardiovascular apparatus
JOP/2020/0012A JOP20200012A1 (ar) 2017-07-26 2018-07-26 تركيبة للاستخدام في الوقاية من مَرَضِيَّات جهاز القلبي الوعائي ومعالجتها
EP18762623.9A EP3657963A1 (en) 2017-07-26 2018-07-26 Composition for use in the prevention and treatment of pathologies of the cardiovascular apparatus
BR112020000902-4A BR112020000902B1 (pt) 2017-07-26 2018-07-26 Composição para uso na prevenção e no tratamento de patologias do aparelho cardiovascular, e uso de uma mistura
JP2020502672A JP2020528888A (ja) 2017-07-26 2018-07-26 心血管器官の病態の予防及び処置における使用のための組成物
PCT/IB2018/055586 WO2019021232A1 (en) 2017-07-26 2018-07-26 Composition for use in the prevention and treatment of pathologies of the cardiovascular apparatus
CONC2020/0000526A CO2020000526A2 (es) 2017-07-26 2020-01-17 Composición para su uso en la prevención y el traramiento de patologías del aparato cardiovascular
PH12020550031A PH12020550031A1 (en) 2017-07-26 2020-01-17 Composition for use in the prevention and treatment of pathologies of the cardiovascular apparatus
CL2020000170A CL2020000170A1 (es) 2017-07-26 2020-01-20 Composición para su uso en la prevención y el tratamiento de patologías del aparato cardiovascular.
ZA2020/00461A ZA202000461B (en) 2017-07-26 2020-01-23 Composition for use in the prevention and treatment of pathologies of the cardiovascular apparatus
JP2023076299A JP2023090869A (ja) 2017-07-26 2023-05-02 心血管器官の病態の予防及び処置における使用のための組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102017000085412A IT201700085412A1 (it) 2017-07-26 2017-07-26 Composizione per uso nella prevenzione e nel trattamento di patologie dell'apparato cardiovascolare

Publications (1)

Publication Number Publication Date
IT201700085412A1 true IT201700085412A1 (it) 2019-01-26

Family

ID=60451085

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102017000085412A IT201700085412A1 (it) 2017-07-26 2017-07-26 Composizione per uso nella prevenzione e nel trattamento di patologie dell'apparato cardiovascolare

Country Status (19)

Country Link
US (1) US20200206157A1 (https=)
EP (1) EP3657963A1 (https=)
JP (2) JP2020528888A (https=)
KR (1) KR20200032691A (https=)
CN (1) CN111031813A (https=)
BR (1) BR112020000902B1 (https=)
CA (1) CA3070659A1 (https=)
CL (1) CL2020000170A1 (https=)
CO (1) CO2020000526A2 (https=)
EA (1) EA202090069A1 (https=)
IL (1) IL272138B2 (https=)
IT (1) IT201700085412A1 (https=)
JO (1) JOP20200012A1 (https=)
MA (1) MA49794A (https=)
MX (1) MX2020000806A (https=)
PE (1) PE20200794A1 (https=)
PH (1) PH12020550031A1 (https=)
WO (1) WO2019021232A1 (https=)
ZA (1) ZA202000461B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201700089258A1 (it) 2017-08-02 2019-02-02 Pharmanutra S P A Composizione per uso nella prevenzione e nel trattamento di carenza di ferro
WO2019237054A1 (en) 2018-06-08 2019-12-12 Epizon Pharma, Inc. Methods and compositions for preventing or treating calciphylaxis
MX2020013302A (es) 2018-06-08 2021-05-12 Epizon Pharma Inc Métodos y composiciones para prevenir o tratar calcificación de tejido.
IT201900007326A1 (it) 2019-05-27 2020-11-27 Alesco Srl Composizioni comprendenti acidi grassi cetilati e loro uso nel trattamento di artriti e stati infiammatori articolari
IT201900007311A1 (it) 2019-05-27 2020-11-27 Alesco Srl Procedimento per la preparazione di una composizione comprendente acidi grassi cetilati
CN114748486A (zh) * 2022-03-25 2022-07-15 南京盛德生物科技研究院有限公司 一种含有维生素k2改善心血管钙化的药物组合物及其制备方法与应用
JP2025518284A (ja) 2022-05-31 2025-06-12 リージョン スイダンマーク 冠動脈石灰化（ｃａｃ）の治療に使用するためのビタミンｋ２

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6039978A (en) * 1995-06-06 2000-03-21 Campbell Soup Company Dietary food enhancement agent
US6361800B1 (en) * 2000-04-13 2002-03-26 Cooper Concepts, Inc. Multi-vitamin and mineral supplement
WO2004019923A1 (en) * 2002-08-30 2004-03-11 Vitak Bv Compositions comprising vitamin k for treating or preventing age-related stiffening of arteries
US20050281888A1 (en) * 2004-06-16 2005-12-22 Chandra Ranjit K Nutritional supplement for infants
WO2006055526A2 (en) * 2004-11-16 2006-05-26 Nu-Tein Co., Inc. Compositions useful to treat ocular neovascular diseases and macular degeneration
US20070148259A1 (en) * 2005-12-23 2007-06-28 Ajay Gupta Parenteral nutrition composition containing iron
US20100021573A1 (en) * 2008-07-22 2010-01-28 Michael J Gonzalez Compositions and methods for the prevention of cardiovascular disease
EP2380578A1 (en) * 2008-12-25 2011-10-26 I.B.E. Co., Ltd. Bioactive agent, pharmaceutical product, cosmetic product, freshness keeping agent, and plant and animal growth promoting agent
WO2012161572A1 (en) * 2011-05-20 2012-11-29 Friesland Brands B.V. Composition comprising vitamin k2
EP2886129A1 (en) * 2013-12-20 2015-06-24 VitaK B.V. Prevention and counteraction of diet-induced thrombosis risk
WO2016131993A2 (en) * 2015-02-20 2016-08-25 Vitak B.V. Vitamin k and capillary function

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3860849B2 (ja) * 1994-04-28 2006-12-20 エーザイ・アール・アンド・ディー・マネジメント株式会社 抗動脈硬化治療剤
CN101094681A (zh) * 2003-10-28 2007-12-26 爱默蕾大学 透析液及其相关方法和系统
EP3066923B1 (en) * 2006-01-30 2025-11-05 Panion & BF Biotech Inc. Method of treating chronic kidney disease
ITMI20121350A1 (it) * 2012-07-31 2014-02-01 Alesco Srl Composizione solido a base di ferro per uso nelle condizioni di deficienza di ferro.
US11344575B2 (en) * 2016-08-15 2022-05-31 Summit Innovation Labs, LLC Vascular calcification prevention and treatment

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6039978A (en) * 1995-06-06 2000-03-21 Campbell Soup Company Dietary food enhancement agent
US6361800B1 (en) * 2000-04-13 2002-03-26 Cooper Concepts, Inc. Multi-vitamin and mineral supplement
WO2004019923A1 (en) * 2002-08-30 2004-03-11 Vitak Bv Compositions comprising vitamin k for treating or preventing age-related stiffening of arteries
US20050281888A1 (en) * 2004-06-16 2005-12-22 Chandra Ranjit K Nutritional supplement for infants
WO2006055526A2 (en) * 2004-11-16 2006-05-26 Nu-Tein Co., Inc. Compositions useful to treat ocular neovascular diseases and macular degeneration
US20070148259A1 (en) * 2005-12-23 2007-06-28 Ajay Gupta Parenteral nutrition composition containing iron
US20100021573A1 (en) * 2008-07-22 2010-01-28 Michael J Gonzalez Compositions and methods for the prevention of cardiovascular disease
EP2380578A1 (en) * 2008-12-25 2011-10-26 I.B.E. Co., Ltd. Bioactive agent, pharmaceutical product, cosmetic product, freshness keeping agent, and plant and animal growth promoting agent
WO2012161572A1 (en) * 2011-05-20 2012-11-29 Friesland Brands B.V. Composition comprising vitamin k2
EP2886129A1 (en) * 2013-12-20 2015-06-24 VitaK B.V. Prevention and counteraction of diet-induced thrombosis risk
WO2016131993A2 (en) * 2015-02-20 2016-08-25 Vitak B.V. Vitamin k and capillary function

Also Published As

Publication number Publication date
WO2019021232A1 (en) 2019-01-31
JOP20200012A1 (ar) 2020-01-26
JP2023090869A (ja) 2023-06-29
EP3657963A1 (en) 2020-06-03
IL272138B2 (en) 2023-09-01
CA3070659A1 (en) 2019-01-31
MX2020000806A (es) 2020-08-17
ZA202000461B (en) 2021-03-31
BR112020000902A2 (pt) 2020-07-21
JP2020528888A (ja) 2020-10-01
CO2020000526A2 (es) 2020-02-18
PE20200794A1 (es) 2020-08-10
MA49794A (fr) 2020-06-03
CN111031813A (zh) 2020-04-17
IL272138B1 (en) 2023-05-01
KR20200032691A (ko) 2020-03-26
US20200206157A1 (en) 2020-07-02
BR112020000902B1 (pt) 2024-03-12
IL272138A (en) 2020-03-31
PH12020550031A1 (en) 2021-02-08
EA202090069A1 (ru) 2020-04-10
CL2020000170A1 (es) 2020-10-30

Similar Documents

Publication Publication Date Title
IL280710A (en) Methods and compositions for treating mitochondrial disease or disorders and heteroplasmy
SG11202106144VA (en) Compositions for the delivery of therapeutic agents and methods of use and making thereof
IT201700085412A1 (it) Composizione per uso nella prevenzione e nel trattamento di patologie dell'apparato cardiovascolare
IL255203B (en) Topical pharmaceutical emulsion compositions comprising 3,5-dihydroxy-4-isopropyl-trans-stilbene and use thereof in the treatment or prophylaxis of dermatological conditions or disorders
SI3377637T1 (sl) Sestavki za uporabo pri postopkih za zdravljenje ran, motenj in bolezni kože
PL3381451T3 (pl) Kompozycja farmaceutyczna stosowana do redukcji zlokalizowanej tkanki tłuszczowej i zastosowanie kompozycji farmaceutycznej
IT201700025666A1 (it) Composizione per l’uso nel trattamento dell’ipercolesterolemia e nella prevenzione di patologie cardiovascolari.
IL280827A (en) Integrin alpha 4 antagonists and compositions comprising same for use in treating ocular conditions
SG11202011296VA (en) Compositions and methods for the treatment of parkinson's disease
SG11202004408YA (en) Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases
IT201700089258A1 (it) Composizione per uso nella prevenzione e nel trattamento di carenza di ferro
EP3261446A4 (en) Methods and compositions for the treatment or prevention of parkinson's disease
IL272495A (en) Pharmaceutical compounds and preparations thereof for use in the treatment of leiftic diseases
IL265911A (en) Epilimod preparations and methods of using them in the treatment of Alzheimer's disease
SI3373922T1 (sl) Sestavki in postopki za uporabo pri zdravljenju homocistinurije
IT201600081379A1 (it) Composizione farmaceutica per uso nel trattamento delle patologie prostatiche.
ZA202101489B (en) Compositions and methods for the treatment of parkinson's disease
IT201700030541A1 (it) Composizione e kit per uso nella prevenzione dell’onicomicosi recidivante
IT201600130012A1 (it) Composizione per uso nel trattamento di disturbi dell'apparato uro-genitale
EP3843690A4 (en) Personal care spray compositions and methods comprising trans-1-chloro-3,3,3-trifluoropropene
EP3582817C0 (en) Tissue scaffold and scaffold composition
IL282703A (en) Novel compounds useful for treating cardiovascular diseases
IT201600122310A1 (it) Composizione per uso nella terapia di alterazioni dell'intestino
IT201700090582A1 (it) Composizione per l’uso nella prevenzione e/o nel trattamento di disturbi gastrici o gastroesofagei.
PL3515409T3 (pl) Kompleks i kompozycje do leczenia chorób okulistycznych i dermatologicznych